# Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)

> **NCT02219633** · PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 30 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** LEO 39652 cream

## Key facts

- **NCT ID:** NCT02219633
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2014-12
- **Final completion:** 2015-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2025-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02219633

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02219633, "Effect of LEO 39652 Cream in Adults With Mild to Moderate Atopic Dermatitis (AD)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02219633. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*